China Money Network
Login
Join

Significant $8.8 Billion Deal! Sino Bio Works Partners with Lilly to Develop New Cancer Immunotherapy Drugs

  • February 9, 2026 — 12:30 CST

This Data Is Locked!

This area is available only to Subscribers.

Sino Bio Works (01801.HK) announced a strategic collaboration with Lilly Pharmaceuticals to advance global research and development of innovative drugs in the fields of oncology... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: